English
Paperback
₹4802
(All inclusive*)
Delivery Options
Please enter pincode to check delivery time.
*COD & Shipping Charges may apply on certain items.
Review final details at checkout.
Looking to place a bulk order? SUBMIT DETAILS
Piracy-free
Assured Quality
Secure Transactions
About The Book
Description
Author
Doxorubicin is regarded as the most therapeutic active agent available for triple-negative breast cancer (TNBC) treatment. However the development of drug resistance and toxicity limits its effectiveness. Thus developing novel strategies for TNBC treatment remains a significant challenge and doxorubicin-based combinations either by metal complexes (Copper I nicotinate complex) or with autophagy modulators could provide novel strategies and alternative strategies contributed to cancer cell death pathways autophagy and apoptosis.
Piracy-free
Assured Quality
Secure Transactions
Delivery Options
Please enter pincode to check delivery time.
*COD & Shipping Charges may apply on certain items.
Review final details at checkout.
Details
ISBN 13
9786139444953
Publication Date
-25-01-2019
Pages
-124
Weight
-171 grams
Dimensions
-150x220x6.97 mm
